Skip to content

Postpartum Psychosis: Diagnosis, Treatment, Lithium, and Relapse Prevention with Dr. Veerle Bergink

Psychiatry & Psychotherapy Podcast

Hosted by David Puder

52m
Transcript

Original podcast

Summary

Written by a model from the transcript; not yet reviewed.

This episode explores the diagnosis, acute treatment, and relapse prevention of postpartum psychosis with Dr. Veerle Bergink, Director of Mount Sinai's Women's Mental Health Center. The discussion covers a detailed clinical case study, walking through early warning signs such as severe insomnia and mood swings, the importance of ruling out somatic and autoimmune causes like anti-NMDA receptor encephalitis or thyroiditis, and the dramatic drop in relapse rates achieved through postpartum lithium maintenance. The guest and host also argue for systemic changes in the United States, including the creation of inpatient mother-baby units and the inclusion of childbirth-related psychiatric chapters in the DSM.

  • Rule out infections and postpartum thyroiditis as somatic triggers when evaluating a patient for postpartum psychosis. 4:51
  • Screen patients presenting with rigidity and tremor after starting a first-generation antipsychotic for anti-NMDA receptor encephalitis. 6:57
  • Exercise caution with SSRIs in the immediate postpartum period to avoid triggering mania or psychosis in vulnerable patients. 22:19
  • Prevent postpartum psychosis recurrences in high-risk patients by starting lithium immediately upon delivery. 51:13

Chapters

  1. 0:13
    Podcast Introduction and Host Greeting

    The host welcomes listeners and introduces Dr. Veerle Bergink, outlining the episode’s focus on postpartum psychosis.

  2. 1:05
    Diagnostic Approach and Initial Management

    Dr. Bergink explains how to assess and admit a patient with suspected postpartum psychosis, emphasizing the importance of ruling out medical causes and initiating sleep and antipsychotic treatment.

  3. 5:23
    Mother‑Baby Units: Need and Funding

    The hosts discuss the lack of mother‑baby units in the U.S., their benefits, and strategies for securing insurance and funding.

  4. 6:51
    Antipsychotic Selection and Autoimmune Considerations

    The discussion turns to choosing antipsychotics, recognizing side‑effects, and the need to screen for anti‑NMDA receptor encephalitis in postpartum psychosis.

  5. 24:49
    Challenges of Lithium Use in the U.S.

    The conversation covers cultural and systemic barriers to lithium prescription in the United States and compares international usage patterns.

  6. 37:55
    DSM Classification and the Push for a Childbirth Chapter

    Dr. Bergink explains the effort to classify postpartum psychiatric disorders in the DSM, including criteria, advocacy, and the importance of a dedicated childbirth chapter.

  7. 44:06
    Rare Postpartum Disorders and Their Place in DSM

    The episode touches on the rarity of postpartum OCD and PTSD, and why they are not prioritized in the DSM classification effort.

  8. 50:41
    Lithium’s Role in Acute and Long‑Term Prevention

    Dr. Bergink details why lithium is essential for preventing relapse after the acute phase, including timing, dosing, and monitoring.

Highlights

  • 2:09

    Recognizing Postpartum Psychosis Symptomsstory

    The guest outlines the rapid progression from postpartum insomnia and obsessive worry to mood-incongruent delusions and disorganized behavior within the first week after delivery.

  • 6:51

    Neurological Signs of Autoimmune Encephalitisinsight

    Extrapyramidal symptoms like rigidity, tremor, and bradycinesia after starting an antipsychotic can point toward an underlying autoimmune encephalitis requiring a spinal tap or blood test.

  • 9:26

    The Postpartum Immune System Resetinsight

    Pregnancy suppresses the adaptive immune system to protect the fetus, while the postpartum period triggers an immune revving that unmasks autoimmune conditions and bipolar relapses.

  • 13:44

    High Remission Rates in Psychosisdata

    Data from the guest's cohort shows that roughly 98 percent of patients with postpartum psychosis achieve full remission of both psychotic and depressive symptoms when properly treated.

  • 15:41

    Half of First Episodes Relapse Without Maintenancedata

    Without maintenance therapy, about half of women with first-onset postpartum psychosis experience a recurrence, while the other half have a postpartum-only illness.

  • 17:36

    Unpredictability of Long-Term Medication Needinsight

    Clinicians cannot reliably predict which patients can safely taper medication after one year, making a trial discontinuation a difficult diagnostic test.

  • 26:59

    Lithium Drastically Reduces Relapse Ratesdata

    Comparative data shows that patients who take lithium alongside antipsychotics during the acute phase have significantly lower relapse rates at one year compared to antipsychotics alone.

  • 37:55

    Pushing for DSM Classificationdebate

    Despite broad clinical agreement, postpartum psychosis has lacked formal DSM classification for years, hampering standardized research, funding, and international treatment guidelines.

Quotes

  • “We have seen many women getting better on Haldol, but yeah, also, olentipin is a good treatment option before the night.”
    Unnamed speaker · 6:10
  • “We know at other times that, you know, lithium is not for everyone, right?”
    Unnamed speaker · 28:42
  • “If you can measure it in blood, but ideally, you do a spinal tap, if you can motivate the patient to actually do that.”
    Unnamed speaker · 7:21

About this episode

In this essential episode of the Psychiatry & Psychotherapy Podcast, Dr. David Puder sits down with internationally renowned expert Dr. Veerle Bergink, Director of Mount Sinai's Women's Mental Health Center, for an in-depth discussion of postpartum psychosis. Covering early warning signs and symptoms, differential diagnosis including anti-NMDA receptor encephalitis and thyroid issues, a highly effective acute treatment algorithm using benzodiazepines, antipsychotics, and lithium, the remarkable 98% remission rates with proper care, lithium's superior role in preventing relapse during the first postpartum year, the simple but powerful prophylaxis strategy of "baby out, lithium in" for high-risk women with bipolar disorder or prior episodes, the urgent need for mother-baby psychiatric units in the U. S., and the ongoing push to formally classify postpartum psychosis in the DSM. Link to blog https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/episode-280-postpartum-psychosis-diagnosis-treatment-lithium-and-relapse-prevention-with-dr-veerle-bergink Link to YouTube video https://youtu.be/fW9xmccggV4 By listening to this episode, you can earn 0.75 Psychiatry CME Credits. https://gecko-ladybug-pa2l.squarespace.com/cme-program

Transcript

0:00
52:12

7,754 words · 2 speakers

Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.

Topics

  • Lithium
  • DSM
  • Haldol
  • ECT
  • Olentipin
  • postpartum thyroiditis
  • Mount Sinai
  • Depakote
  • Lamotrigine
  • NMDA antibodies

Page updated · transcript and summary are machine-generated